tobramycin has been researched along with B cepacia Infection in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.17) | 18.2507 |
| 2000's | 11 (45.83) | 29.6817 |
| 2010's | 12 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caljon, G; Cappoen, D; Coenye, T; Cools, F; Cos, P; Delputte, P; Maes, L; Maira, BM; Martinet, W; Torfs, E; Vanhoutte, B | 1 |
| Antony, VB; Carden, JL; Gaggar, A; Garcia, BA; Goodwin, DL; Leon, K; Rowe, SM; Smith, TA; Solomon, GM | 1 |
| Kemper, AL; Young, DC; Zobell, JT | 1 |
| Coenye, T; Messiaen, AS; Nelis, H | 1 |
| LiPuma, JJ; Matukas, L; Ratjen, A; Speert, DP; Tullis, E; Waters, V; Wettlaufer, J; Yau, Y; Zlosnik, JE | 1 |
| Cooper, R; Howe, R; Jenkins, R; Wootton, M | 1 |
| Gilchrist, FJ; Kitt, H; Lenney, W | 1 |
| Acke, M; Coenye, T; Cools, F; Cos, P; Gielis, J; Van Acker, H | 1 |
| Brackman, G; Cappoen, D; Coenye, T; Cos, P; Crabbé, A; Rigole, P; Van den Driessche, F; Vanhoutte, B; Vercruysse, J; Verstraete, G; Vervaet, C | 1 |
| Beaudoin, T; Klingel, M; McDonald, N; Ratjen, F; Rizvi, L; Tom, SK; Tullis, E; Waters, V; Wettlaufer, J; Yau, Y | 1 |
| George, AM; Iredell, J; Middleton, PG; Treerat, P; Widmer, F | 1 |
| Bertram, C; Elborn, JS; Hodson, M | 1 |
| Grimwood, K; Kidd, TJ; Tweed, M | 1 |
| Church, AC; Foweraker, J; Parmer, J; Sivasothy, P | 1 |
| Ball, R; Brownlee, KG; Conway, SP; Denton, M; Duff, AJ; Lee, TW | 1 |
| Adams, S; Ericson, DA; Gerard, C; Kalish, LA; Uluer, AZ; Waltz, DA | 1 |
| Ducharme, MP; Lavigne, J; Marier, JF | 1 |
| Davis, JM; Domenico, P; Gurzenda, E; Kazzaz, JA; LiPuma, JJ; Veloira, WG | 1 |
| Kidd, TJ; Middleton, PG; Williams, B | 1 |
| Blumer, JL; Konstan, MW; Melnick, D; Saiman, L | 1 |
| Hasan, MA; Lange, CF | 1 |
| Elborn, JS; McElnay, JC; Moriarty, TF; Tunney, MM | 1 |
| Dodd, ME; Jones, AM; Webb, AK; Weidmann, A | 1 |
| Bingen, E; Bonacorsi, S; Fitoussi, F; Lhopital, S | 1 |
1 review(s) available for tobramycin and B cepacia Infection
| Article | Year |
|---|---|
Mediastinal abscess after lung transplantation secondary to Burkholderia gladioli infection.
Topics: Abscess; Adult; Anti-Bacterial Agents; Burkholderia gladioli; Burkholderia Infections; Combined Modality Therapy; Cystic Fibrosis; Diagnosis, Differential; Drainage; Drug Therapy, Combination; Humans; Infusions, Intravenous; Lung Transplantation; Male; Mediastinal Diseases; Meropenem; Opportunistic Infections; Postoperative Complications; Thienamycins; Tobramycin; Tomography, X-Ray Computed | 2009 |
6 trial(s) available for tobramycin and B cepacia Infection
| Article | Year |
|---|---|
Pilot trial of tobramycin inhalation powder in cystic fibrosis patients with chronic Burkholderia cepacia complex infection.
Topics: Administration, Inhalation; Adolescent; Adult; Anti-Bacterial Agents; Burkholderia cepacia complex; Burkholderia Infections; Canada; Child; Cystic Fibrosis; Drug Monitoring; Female; Forced Expiratory Volume; Humans; Male; Pilot Projects; Respiratory Tract Infections; Sputum; Tobramycin; Treatment Outcome | 2017 |
Can Burkholderia cepacia complex be eradicated with nebulised amiloride and TOBI?
Topics: Adolescent; Amiloride; Anti-Bacterial Agents; Burkholderia cepacia complex; Burkholderia Infections; Child; Cystic Fibrosis; Drug Therapy, Combination; Humans; Nebulizers and Vaporizers; Sodium Channel Blockers; Tobramycin | 2010 |
Inhaled amiloride and tobramycin solutions fail to eradicate Burkholderia dolosa in patients with cystic fibrosis.
Topics: Administration, Inhalation; Amiloride; Anti-Bacterial Agents; Burkholderia Infections; Chronic Disease; Drug Synergism; Drug Therapy, Combination; Endpoint Determination; Humans; Tobramycin; Treatment Failure | 2013 |
The efficacy and safety of meropenem and tobramycin vs ceftazidime and tobramycin in the treatment of acute pulmonary exacerbations in patients with cystic fibrosis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Burkholderia cepacia; Burkholderia Infections; Ceftazidime; Child; Child, Preschool; Cystic Fibrosis; Disease Progression; Drug Therapy, Combination; Forced Expiratory Volume; Humans; Meropenem; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Function Tests; Sputum; Thienamycins; Tobramycin | 2005 |
Estimating in vivo airway surface liquid concentration in trials of inhaled antibiotics.
Topics: Administration, Inhalation; Aerosols; Anti-Bacterial Agents; Burkholderia cepacia; Burkholderia Infections; Computer Simulation; Cystic Fibrosis; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Models, Biological; Nebulizers and Vaporizers; Particle Size; Pseudomonas aeruginosa; Pseudomonas Infections; Research Design; Respiratory Mechanics; Respiratory System; Sputum; Taurine; Thiadiazines; Tobramycin | 2007 |
Sputum antibiotic concentrations: implications for treatment of cystic fibrosis lung infection.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Area Under Curve; Burkholderia cepacia; Burkholderia Infections; Ceftazidime; Cystic Fibrosis; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Humans; Infusions, Intravenous; Microbial Sensitivity Tests; Middle Aged; Pseudomonas Infections; Sputum; Tobramycin | 2007 |
17 other study(ies) available for tobramycin and B cepacia Infection
| Article | Year |
|---|---|
Optimization and characterization of a murine lung infection model for the evaluation of novel therapeutics against Burkholderia cenocepacia.
Topics: Animals; Anti-Bacterial Agents; Burkholderia cenocepacia; Burkholderia Infections; Cytokines; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Liver; Lung; Mice; Mice, Inbred BALB C; Pneumonia; Respiratory Tract Infections; Spleen; Tobramycin | 2017 |
Implementation of a successful eradication protocol for Burkholderia Cepacia complex in cystic fibrosis patients.
Topics: Administration, Inhalation; Administration, Intravenous; Administration, Oral; Adult; Anti-Bacterial Agents; Azithromycin; Burkholderia cepacia complex; Burkholderia Infections; Ceftazidime; Clinical Protocols; Cohort Studies; Consolidation Chemotherapy; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Induction Chemotherapy; Male; Middle Aged; Pneumonia, Bacterial; Retrospective Studies; Tobramycin; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2018 |
The use of doripenem in pediatric cystic fibrosis patients in case of meropenem shortages.
Topics: Adolescent; Anti-Bacterial Agents; Burkholderia cenocepacia; Burkholderia Infections; Carbapenems; Child; Cystic Fibrosis; Disease Progression; Doripenem; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Meropenem; Pseudomonas aeruginosa; Pseudomonas Infections; Pseudomonas stutzeri; Rhodospirillaceae; Thienamycins; Tobramycin; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2014 |
Investigating the role of matrix components in protection of Burkholderia cepacia complex biofilms against tobramycin.
Topics: Anti-Bacterial Agents; beta-Glucans; Biofilms; Burkholderia cepacia; Burkholderia Infections; Cystic Fibrosis; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Polysaccharides, Bacterial; Tobramycin; Virulence; Virulence Factors | 2014 |
In vitro efficacy of high-dose tobramycin against Burkholderia cepacia complex and Stenotrophomonas maltophilia isolates from cystic fibrosis patients.
Topics: Anti-Bacterial Agents; Biofilms; Burkholderia cepacia complex; Burkholderia Infections; Cystic Fibrosis; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Stenotrophomonas maltophilia; Tobramycin | 2015 |
A demonstration of the susceptibility of clinical isolates obtained from cystic fibrosis patients to manuka honey.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Burkholderia; Burkholderia Infections; Colistin; Cystic Fibrosis; Honey; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2015 |
Two case reports of the successful eradication of new isolates of Burkholderia cepacia complex in children with cystic fibrosis.
Topics: Administration, Inhalation; Adolescent; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Burkholderia cepacia complex; Burkholderia Infections; Ceftazidime; Child; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; England; Female; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Penicillins; Tobramycin; Treatment Outcome | 2016 |
The Role of Reactive Oxygen Species in Antibiotic-Induced Cell Death in Burkholderia cepacia Complex Bacteria.
Topics: Anti-Bacterial Agents; Biofilms; Burkholderia cepacia complex; Burkholderia Infections; Cell Death; Ciprofloxacin; Gene Expression Regulation, Bacterial; Meropenem; Microbial Sensitivity Tests; Reactive Oxygen Species; Repressor Proteins; Thienamycins; Tobramycin | 2016 |
Evaluation of combination therapy for Burkholderia cenocepacia lung infection in different in vitro and in vivo models.
Topics: A549 Cells; Animals; Biofilms; Burkholderia cenocepacia; Burkholderia Infections; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combination; Econazole; Female; Humans; Mice; Mice, Inbred BALB C; Miconazole; Pneumonia, Bacterial; Tobramycin | 2017 |
In vitro interactions of tobramycin with various nonantibiotics against Pseudomonas aeruginosa and Burkholderia cenocepacia.
Topics: Amiloride; Burkholderia cepacia complex; Burkholderia Infections; Cystic Fibrosis; Drug Interactions; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Membrane Transport Modulators; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2008 |
Implementation of European standards of care for cystic fibrosis--control and treatment of infection.
Topics: Administration, Inhalation; Adult; Anti-Bacterial Agents; Bacterial Infections; Burkholderia cepacia; Burkholderia Infections; Child; Child, Preschool; Ciprofloxacin; Colistin; Cystic Fibrosis; Europe; Guideline Adherence; Humans; Infection Control; Practice Guidelines as Topic; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Surveys and Questionnaires; Tobramycin; Young Adult | 2009 |
Successful treatment of cepacia syndrome.
Topics: Anti-Bacterial Agents; Burkholderia cepacia; Burkholderia Infections; Child; Cystic Fibrosis; Deoxyribonuclease I; Drug Therapy, Combination; Female; Humans; Radiography; Tobramycin | 2009 |
Pharmacokinetics and efficacies of liposomal and conventional formulations of tobramycin after intratracheal administration in rats with pulmonary Burkholderia cepacia infection.
Topics: Animals; Burkholderia cepacia; Burkholderia Infections; Half-Life; Intubation, Intratracheal; Liposomes; Lung Diseases; Male; Rats; Rats, Sprague-Dawley; Tobramycin | 2002 |
In vitro activity and synergy of bismuth thiols and tobramycin against Burkholderia cepacia complex.
Topics: Anti-Bacterial Agents; Bismuth; Burkholderia cepacia; Burkholderia Infections; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Sulfhydryl Compounds; Tobramycin | 2003 |
Combination aerosol therapy to treat Burkholderia cepacia complex.
Topics: Administration, Inhalation; Adult; Amiloride; Anti-Bacterial Agents; Burkholderia cepacia complex; Burkholderia Infections; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Male; Nebulizers and Vaporizers; Sodium Channel Blockers; Tobramycin | 2005 |
Successful treatment of cepacia syndrome with combination nebulised and intravenous antibiotic therapy.
Topics: Adult; Anti-Bacterial Agents; Burkholderia cepacia; Burkholderia Infections; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Meropenem; Nebulizers and Vaporizers; Syndrome; Thienamycins; Tobramycin | 2008 |
Comparative in vitro activities of meropenem, imipenem, temocillin, piperacillin, and ceftazidime in combination with tobramycin, rifampin, or ciprofloxacin against Burkholderia cepacia isolates from patients with cystic fibrosis.
Topics: Burkholderia cepacia; Burkholderia Infections; Ceftazidime; Ciprofloxacin; Cystic Fibrosis; Drug Synergism; Drug Therapy, Combination; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillins; Piperacillin; Rifampin; Thienamycins; Tobramycin | 1999 |